Treatment of Psoriasis with Interleukin-10
- 1 December 1998
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 111 (6), 1235-1236
- https://doi.org/10.1046/j.1523-1747.1998.00444.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study GroupGastroenterology, 1997
- Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.The Journal of Experimental Medicine, 1995
- Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basisNature Medicine, 1995
- 20 MHz sonography, colorimetry and image analysis in the evaluation of psoriasis vulgarisJournal of Dermatological Science, 1995
- Keratinocyte Interleukin-10 Expression Is Upregulated in Tape-Stripped Skin, Poison Ivy Dermatitis, and Sezary Syndrome, but Not in Psoriatic PlaquesClinical Immunology and Immunopathology, 1994
- The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated ResponseJournal of Investigative Dermatology, 1993
- CD4 antibody treatment of severe psoriasisThe Lancet, 1991